SenesTech, Inc. (SNES) News
Filter SNES News Items
SNES News Results
|Loading, please wait...|
SNES News Highlights
- SNES's 30 day story count now stands at 6.
- Over the past 19 days, the trend for SNES's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about SNES are PRE.
Latest SNES News From Around the Web
Below are the latest news stories about SENESTECH INC that investors may wish to consider to help them evaluate SNES as an investment opportunity.
SenesTech Expands Distribution with DIY Pest Control Through Initial Stocking Order of EVOLVE Soft Bait Fertility Control Product
SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the leader in fertility control to manage animal pest populations, today announced that it has renewed and expanded its distribution with DIY Pest Control with a stocking order for Evolve™ Soft Bait ("Evolve"), the first and only soft bait product featuring breakthrough, next generation technology that targets rodent populations by using nonlethal methods to restrict fertility. DIY Pest Control is a leading online
SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company") (www.senestech.com), the leader in fertility control to manage animal pest populations, today announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 12 pre-split shares. The reverse stock split will become effective at 4:01 p.m, Eastern Time, on November 16, 2023. The Company's common stock will continue to be traded on the Nasdaq Capital Market under the symbol "SNES" a
Pre-market stock movers are worth checking out on Monday as we cover all of the biggest gainers and losers this morning!
SenesTech stock is rocketing higher on Monday with heavy trading of SNES despite a lack of news from the animal fertility management company.
Collective Audience stock is rising higher on Monday with heavy trading of CAUD shares despite a lack of news from the company.
Verve Therapeutics stock is falling on Monday even after the company posted promising interim data from a Phase 1b clinical trial.
SenesTech, Inc. (NASDAQ:SNES) Q3 2023 Earnings Call Transcript November 9, 2023 SenesTech, Inc. beats earnings expectations. Reported EPS is $-0.47, expectations were $-0.85. Operator: Good afternoon. And welcome to the SenesTech Reports Third Quarter Fiscal Year 2023 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will […]
SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the leader in fertility control to manage animal pest populations, today announced financial results for the third quarter of 2023.
SenesTech, Inc. (NASDAQ: SNES) will report financial results for its third quarter 2023, ended September 30, 2023, after the market close on Thursday, November 9, 2023. The Company has scheduled a conference call that same day, Thursday, November 9, 2023, at 5:00 pm ET, to review the results.
SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, announces today the Company is now taking orders from commercial customers for Evolve™ Soft Bait ("Evolve™"), a solution designed to reduce fertility in rats, for shipment on or before November 13th. The Company already has received advanced purchase commitments from key customers.